Iyengar Yoga for Young People With Irritable Bowel Syndrome
1 other identifier
interventional
58
1 country
1
Brief Summary
Irritable bowel syndrome (IBS) affects as many as 14% of high school-aged students. Symptoms include discomfort in the abdomen, along with diarrhea and/or constipation and other gastroenterological symptoms, which can significantly impact quality of life and daily functioning of patients. Emotional stress appears to exacerbate IBS symptoms suggesting that mind-body interventions reducing arousal may prove beneficial. Often symptoms can be traced to childhood and adolescence, making the early manifestation of IBS important to understand. The current study focuses on young people aged 14-26 years of age with IBS. The study will test the potential benefits of Iyengar yoga (IY) on clinical symptoms, psychospiritual functioning and visceral sensitivity. Yoga is thought to bring physical, psychological and spiritual benefits to practitioners and has been associated with reduced stress and pain. Through its focus on restoration and use of props, IY is especially designed to decrease arousal and promote psychospiritual resources in physically compromised individuals. Sixty-four IBS patients aged 14-26 will be randomly assigned to a standardized 6-week biweekly IY group-based program (1.5 hour sessions) or a wait-list usual care control group. The groups will be compared on the primary clinical outcomes of IBS symptoms, quality of life and global improvement at post-treatment and 2 month follow-up. Secondary outcomes will include visceral pain sensitivity assessed with a standardized laboratory task (water load task), and psychospiritual variables including coping, self-efficacy, mood, acceptance and mindfulness. It is hypothesized that IY will be safe and feasible: with less than 20% attrition; and the IY group will demonstrate significantly improved outcomes compared to controls, with physiological and psychospiritual mechanisms contributing to improvements; clinical treatment gains will be maintained at 2 months following yoga.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2010
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2010
CompletedFirst Submitted
Initial submission to the registry
April 20, 2010
CompletedFirst Posted
Study publicly available on registry
April 21, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2013
CompletedNovember 28, 2016
November 1, 2016
3.9 years
April 20, 2010
November 23, 2016
Conditions
Outcome Measures
Primary Outcomes (6)
Irritable bowel symptoms
baseline (within 2 weeks of receiving intervention)
Irritable bowel symptoms
post-intervention (within 2 weeks of completing intervention)
Irritable bowel symptoms
follow up (2 months after completion of intervention)
Quality of Life
baseline (within 2 weeks of receiving intervention)
Quality of Life
post-intervention (within 2 weeks of completing intervention)
Quality of Life
follow up (2 months after completion of intervention)
Study Arms (2)
Iyengar yoga
EXPERIMENTALWaitlist control
NO INTERVENTIONInterventions
Eligibility Criteria
You may qualify if:
- Male and female youth will be eligible for the study if they meet the following criteria:
- Age 14-26 years.
- Diagnosis of IBS, using ROME III pediatric criteria for patients aged 14-17 years, and ROME III adult criteria for 18-26 year-olds.
- Able and willing to give written informed assent or consent and comply with the requirements of the study protocol.
- Ability to speak and understand English.
You may not qualify if:
- Any other injury, disease, metabolic dysfunction, physical examination finding, or clinical laboratory finding giving reasonable suspicion that it might affect the interpretation of the results or render the patient at high risk from treatment complications.
- Inability to comply with study and follow-up procedures.
- Currently pregnant.
- Previous practice of yoga within the past three months.
- Inability to speak and understand English.
- Plan to begin a new treatment within 2 weeks of the IYP.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UCLA Pediatric Pain Program
Los Angeles, California, 90064, United States
Related Publications (2)
Evans S, Lung KC, Seidman LC, Sternlieb B, Zeltzer LK, Tsao JC. Iyengar yoga for adolescents and young adults with irritable bowel syndrome. J Pediatr Gastroenterol Nutr. 2014 Aug;59(2):244-53. doi: 10.1097/MPG.0000000000000366.
PMID: 25025601RESULTEvans S, Cousins L, Tsao JC, Sternlieb B, Zeltzer LK. Protocol for a randomized controlled study of Iyengar yoga for youth with irritable bowel syndrome. Trials. 2011 Jan 18;12:15. doi: 10.1186/1745-6215-12-15.
PMID: 21244698DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Subhadra Evans, Ph.D.
University of California, Los Angeles
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 20, 2010
First Posted
April 21, 2010
Study Start
January 1, 2010
Primary Completion
December 1, 2013
Study Completion
December 1, 2013
Last Updated
November 28, 2016
Record last verified: 2016-11